A New Neutralization Epitope in the Spike Protein of Porcine Epidemic Diarrhea Virus

Porcine epidemic diarrhea virus (PEDV) infects piglets and causes serious diarrhea as well as vomiting, dehydration, and death. The trimeric S protein plays a crucial role in the induction of neutralizing antibodies, and many neutralizing monoclonal antibodies (mAbs) against PEDV S protein have been developed. However, these mAbs exclusively target the S1 protein. In this study, we obtained a neutralizing mAb, 5F7, against the S2 protein of PEDV, and this mAb could neutralize new variant genotype 2 PEDV strains (LNCT2), as well as a genotype 1 PEDV strain (CV777), in vitro. The core sequence of the epitope was found in amino acid sequence 1261 aa~1337 aa. These findings confirm that the S2 protein possessed neutralizing epitopes and provided knowledge to aid further research on this virus.     

猪血凝性脑脊髓炎病毒单克隆抗体的制备与鉴定

目的制备猪血凝性脑脊髓炎病毒(HEV)单克隆抗体,并进行鉴定。方法通过差速离心和蔗糖密度梯度离心法对猪HEV进行纯化,免疫BALB/c小鼠后,取其脾细胞与骨髓瘤SP2/0细胞进行融合,经间接ELISA和血凝抑制试验(HI)筛选能稳定分泌抗HEV单克隆抗体的杂交瘤细胞株,并对单抗进行生物学鉴定。结果筛选出4株能稳定分泌抗HEV单抗的杂交瘤细胞株2H2、2A1、1E2、4D4。经鉴定,4株杂交瘤细胞株诱生小鼠腹水抗HEV的ELISA效价可达1∶12800～1∶51200,其中3株HI效价可达1∶24～1∶28,另1株为0。4株杂交瘤细胞分泌的单抗与猪传染性胃肠炎病毒(TGEV)、猪流行性腹泻病毒(PEDV)和猪伪狂犬病病毒(PRV)均不发生交叉反应;杂交瘤细胞染色体数为83～103;除2A1单抗为IgG2b外,其他3株均为IgG1;Westernblot分析表明,2H2、2A1和4D4能识别HEV的血凝素-酯酶蛋白(HE),1E2可识别纤突蛋白(S)。结论已成功制备出抗HEV的单克隆抗体,为HEV快速检测试剂的研制奠定了基础。     

戊型肝炎病毒在长春地区动物群中的流行病学研究

目的分析戊型肝炎病毒(HEV)在长春地区动物群中的感染情况及戊型肝炎病毒系统进化关系。方法用抗-HEV抗体试剂盒检测长春地区猪、牛、羊、鹿、鸡和马血清中的抗体;对部分血清用RT-PCR检测HEVRNA,并对PCR阳性产物进行克隆测序及序列分析。结果493份猪血清中有427份为抗-HEV抗体阳性,阳性率为86.61%;有5份为HEVRNA阳性,5株克隆的核苷酸序列的同源性为91.2%～99.1%,该5株克隆的序列在ORF2区348bp与1～4型间核苷酸同源性分别为77.8%～82.3%、77.2%～78.1%、77.2%～99.1%和85.2%～95.2%;266份牛血清中有122份为抗-HEV抗体阳性,阳性率为45.86%;93份羊血清中有7份为抗-HEV抗体阳性,阳性率为7.53%;798份鹿血清中有348份为抗-HEV抗体阳性,阳性率为43.61%;369份鸡血清中有18份为抗-HEV抗体阳性,阳性率为4.88%;197份马血清中有31份为抗-HEV抗体阳性,阳性率为15.74%。结论HEV在多种动物群中均有流行,但在猪群中的流行率明显高于其他动物群。猪感染的HEV的基因序列与人群中散发性戊型肝炎病毒的基因4型同源性最高。进化关系表明,在长春地区猪与人HEV应划为一个分支。     

Epitopes Displayed in a Cyclic Peptide Scaffold Bind SARS-COV-2 Antibodies

The SARS-CoV-2 virus that causes COVID-19 is a global health issue. The spread of the virus has resulted in seven million deaths to date. The emergence of new viral strains highlights the importance of continuous surveillance of the SARS-CoV-2 virus by using timely and accurate diagnostic tools. Here, we used a stable cyclic peptide scaffolds to present antigenic sequences derived from the spike protein that are reactive to SARS-CoV-2 antibodies. Using peptide sequences from different domains of SARS-CoV-2 spike proteins, we grafted epitopes on the peptide scaffold sunflower trypsin inhibitor 1 (SFTI-1). These scaffold peptides were then used to develop an ELISA to detect SARS-CoV-2 antibodies in serum. We show that displaying epitopes on the scaffold improves reactivity overall. One of the scaffold peptides (S2_1146-1161_c) has reactivity equal to that of commercial assays, and shows diagnostic potential.     

猪附红细胞体ORF2蛋白的二级结构及其B细胞抗原表位的预测

目的预测猪附红细胞体[亦称猪嗜血支原体(Mycoplasma suis,M.suis)]ORF2基因编码蛋白的二级结构及其B细胞抗原表位。方法应用生物信息学软件DNAstar的Editseq将M.suis中ORF2的基因核苷酸序列翻译成氨基酸序列,与GenBank中登录的氨基酸序列进行比对,通过Protean模块预测ORF2蛋白的二级结构及其亲水性区域、柔韧性区域、抗原指数、表面可及性等特性,并预测B细胞优势抗原表位。结果 ORF2蛋白具有规则的二级结构,多处于亲水性区域、柔韧性区域、表面可及性较大和抗原指数较高的区段,潜在的优势B细胞抗原表位为17²3、12123、121¹27、138127、138¹44、192144、192²00氨基酸区段。结论预测了ORF2蛋白二级结构和B细胞抗原表位,为M.suis表位疫苗的设计以及血清诊断试剂盒的研发奠定了理论基础。     

酿酒酵母钙通道膜蛋白单克隆抗体制备及鉴定

以酿酒酵母电压门控钙通道膜蛋白（Cch1p）、牵张敏感性钙通道膜蛋白（Mid1p）和瞬时受体电位钙通道膜蛋白（Yvc1p）为研究材料，制备其单克隆抗体。采用生物信息学方法确定3种膜蛋白抗原表位，根据分析结果克隆抗原基因，并进行原核表达和表达产物分析鉴定，通过Ni²⁺-NTA树脂亲和层析技术获得重组抗原蛋白，免疫小鼠后细胞融合技术制备单克隆抗体，酶联免疫吸附测定（ELISA）检测抗体效价，免疫印迹技术检测单克隆抗体对重组纯化抗原和天然酿酒酵母钙通道膜蛋白的反应性和特异性。生物信息学分析结果表明，Cch1p、Mid1p和Yvc1p抗原表位可能分别位于1~300位氨基酸残基、359~548位氨基酸残基、1~236位氨基酸残基；克隆目的基因条带大小分别为926bp、570bp和708bp，与预期结果一致；原核表达抗原蛋白分子量分别为60000、25000和30000，Western blot检测条带正确；重组纯化抗原免疫BALB/c小鼠，细胞融合技术制备单克隆抗体，ELISA检测显示单克隆抗体效价分别高达1∶256000、1∶128000和1∶64000，Western blot检测到3种重组纯化抗原和天然酿酒酵母钙通道膜蛋白Cch1p、Mid1p和Yvc1p。这些结果说明本文制备的单克隆抗体可以成功用于检测酿酒酵母钙通道膜蛋白Cch1p、Mid1p和Yvc1p表达的相关研究。     

Identification of Epitopes on Rhinovirus 89 Capsid Proteins Capable of Inducing Neutralizing Antibodies

Rhinoviruses (RVs) are major causes of the common cold, but they can also trigger exacerbations of asthma. More than 160 different RV strains exist and can be classified into three genetic species (RV-A, RV-B and RV-C) which bind to different receptors on human cells including intracellular adhesion molecule 1 (ICAM-1), the low-density lipoprotein receptor (LDLR) or the cadherin-related family member 3 (CDHR3). Epitopes located in the RV capsid have mainly been determined for RV2, a minor-group RV-A strain binding to LDLR, and for RV14, a major-group RV-B strain binding to ICAM-1. In order to study epitopes involved in the neutralization of RV89, an ICAM-1-binding RV-A strain which is highly different from RV2 and RV14 in terms of receptor specificity and sequence, respectively, we analyzed the specificity and epitopes of a highly neutralizing antiserum using recombinantly produced RV89 capsid proteins (VP1, VP2, VP3 and VP4), recombinant fragments and synthetic overlapping peptides thereof. We found that the antiserum which neutralized in vitro RV89 infection up to a dilution of 1:24,000 reacted with the capsid proteins VP1 and VP2 but not with VP3 and VP4. The neutralizing antibodies recognized recombinant fragments comprising approximately 100 amino acids of the N- and C-terminus of VP1 and the middle part of VP2, in particular, three peptides which, according to molecular modeling based on the three-dimensional structure of RV16, were surface-exposed on the viral capsid. Two recombinant fusion proteins containing the identified peptides fused to hepatitis B (HBV)-derived preS as a carrier protein induced upon immunization of rabbits antibodies capable of neutralizing in vitro RV89 infections. Interestingly, the virus-neutralizing epitopes determined for RV89 corresponded to those determined for minor-group RV2 binding to LDL and major-group RV14 belonging to the RV-B species, which are highly different from RV89. Our results indicate that highly different RV strains, even when reacting with different receptors, seem to engage similar parts of their capsid in the infection process. These results may be important for the design of active and passive immunization strategies for RV.     

Epidemiology of Hepatitis E Virus in European Countries

Over the last decade the seroprevalence of immunoglobulin (IgG) anti hepatitis E virus (HEV) has been increasing in European countries and shows significant variability among different geographical areas. In this review, we describe the serological data concerning the general population and risk groups in different European countries. Anti-HEV antibody prevalence ranged from 1.3% (blood donors in Italy) to 52% (blood donors in France). Various studies performed on risk groups in Denmark, Moldova and Sweden revealed that swine farmers have a high seroprevalence of HEV IgG (range 13%–51.1%), confirming that pigs represent an important risk factor in HEV infection in humans. Subtypes 3e,f are the main genotypes detected in the European population. Sporadic cases of autochthonous genotype 4 have been described in Spain, France, and Italy. Although most HEV infections are subclinical, in immune-suppressed and transplant patients they could provoke chronic infection. Fulminant hepatitis has rarely been observed and it was related to genotype 3. Interferon and ribavirin treatment was seen to represent the most promising therapy.     

戊型肝炎病毒ORF2蛋白与新型融合标签Halo Tag的融合表达

目的在大肠杆菌KRX中表达戊型肝炎病毒(Hepatitis E virus,HEV)ORF2与新型融合标签Halo Tag融合蛋白。方法采用RT-PCR法从4型HEV毒株中扩增ORF2基因部分片段(aa 382~620),插入含新型融合标签Halo Tag的原核表达载体pFN18the中,构建重组表达质粒pFN18the-ORF2,转化大肠杆菌KRX,鼠李糖诱导表达Halo-ORF2融合蛋白,纯化后Western blot分析融合蛋白的反应原性。结果经RT-PCR扩增出717 bp的目的基因片段;重组表达质粒pFN18the-ORF2经双酶切和测序鉴定构建正确;表达的融合蛋白Halo-ORF2相对分子质量为57 900,表达量约占菌体总蛋白的15%,以包涵体形式表达,纯化后纯度达90%以上,可与HEV IgG阳性血清特异性结合。结论在大肠杆菌KRX中表达了Halo-ORF2融合蛋白,为HEV结构蛋白抗原表位的筛选及戊肝血清学诊断的研究奠定了基础。     

狂犬病病毒4aG株G蛋白基因的克隆及其生物信息学分析

目的克隆狂犬病病毒(Rabies virus,RV)4aG株G蛋白基因,并与其他疫苗毒株G蛋白基因序列进行比较,为我国狂犬病疫苗的研制提供理论依据。方法从RV 4aG株中扩增G蛋白基因,并进行序列测定,利用生物信息学软件绘制系统进化树,预测G蛋白功能位点、二级结构和B细胞抗原表位,并与其他疫苗毒株进行比较。结果克隆的4aG株G蛋白基因序列与GenBank中登录的序列一致。进化树分析显示,4aG株与CVS株的进化关系较远;4aG、4aGV18、CVS、PV及RC-HL毒株跨膜区域在第460～479氨基酸之间,其他毒株在459～478氨基酸之间;PV株有5个糖基化位点,RV-97株有3个糖基化位点,其他毒株均有4个糖基化位点;G蛋白抗原表位位于氨基酸100～300及480～520之间;不同毒株G蛋白抗原位点区域有所不同,与CVS株比较,PV株抗原表位与其最为接近,4aG、4aGV18、CTN-1-31及Flury-HEP株与其抗原表位较为接近。结论4aG株G蛋白功能位点和抗原表位与CVS株相差较大,但其在Vero细胞上传代稳定,可用于制备Vero细胞纯化疫苗。     

Capture of Uropathogenic E. coli by Using Synthetic Glycan Ligands Specific for the Pap‐Pilus

Biotinylated mono‐ and biantennary di‐/trisaccharides were synthesized to evaluate their ability to capture E. coli strains that express pilus types with different receptor specificities. The synthesized biotinylated di‐/trisaccharides contain Galα(1→4)Gal, Galα(1→4)GalNHAc, GalNHAcα(1→4)Gal, Galα(1→4)Galβ(1→4)Glc and GalNHAcα(1→4)Galβ(1→4)Glc as carbohydrate epitopes. These biotinylated oligosaccharides were immobilized on streptavidin‐coated magnetic beads, and incubated with different strains of live E. coli. Capturing ability was assessed by using a luciferase assay that detects bacterial ATP. The trisaccharides containing Galα(1→4)Galβ(1→4)Glc and the disaccharides containing Galα(1→4)Gal as the epitopes exhibited strong capturing ability for uropathogenic E. coli strains with the pap pilus genotype, including CFT073, J96 and J96 pilE. The same ligands failed to capture E. coli strains with fim, prs, or foc genotypes. Uropathogenic CFT073 was also captured moderately by biantennary disaccharides containing a GalNHAc moiety at the reducing end; however, other saccharides containing GalNHAc at the nonreducing end did not capture the CFT073 strain. These synthetic glycoconjugates could potentially be adapted as rapid diagnostic agents to differentiate between different E. coli pathovars.     

Structurally Refined β‐Lactones as Potent Inhibitors of Devastating Bacterial Virulence Factors

Disarmed forces : Inhibition of the central virulence regulator ClpP by structurally refined β‐lactones resulted in dramatically reduced production of devastating virulence factors, including pyrogenic toxin superantigens derived from pathogenic multiresistant Staphylococcus aureus strains. Targeting of this virulence regulator could present an attractive strategy for neutralizing the harmful effects of bacterial pathogens, and help the host immune response to eliminate the disarmed bacteria.

     

cTnI特殊位点抗原的重复表达、免疫及其抗体效价检测

构建了含人cTnI蛋白稳定区段2个特殊抗原决定簇位点的pMAL-Antigen质粒. 利用BamHI/BgLII两限制性内切酶的同尾酶作用进行连接,在pMAL-p2x质粒的MBP(麦芽糖结合蛋白)之后接入了上述5个相同的片段. 此质粒在大肠杆菌E. coli BL21 (DE3)中经1.0 mmol/L IPTG诱导表达出的融合蛋白MBP-Antigen经Amlyose-resin亲和层析柱纯化后免疫BABL/C小鼠,成功获得了能抗人cTnI和抗牛cTnI的抗血清.     

Behaviour of a tall vertical gas-evolving cell Part II: Distribution of current

Vertical electrolysers with a narrow electrode gap are used to produce gases, for example, chlorine, hydrogen and oxygen. The gas voidage in the solution increases with increasing height in the electrolyser and consequently the current density is expected to decrease with increasing height. Current distribution experiments were carried out in an undivided cell with two electrodes each consisting of 20 equal segments or with a segmented electrode and a one-plate electrode. It was found that for a bubbly flow the current density decreases linearly with increasing height in the cell. The current distribution factor increases with increasing average current density, decreasing volumetric flow rate of liquid and decreasing distance between the anode and the cathode. Moreover, it is concluded that the change in the electrode surface area remaining free of bubbles with increasing height has practically no effect on the current distribution factor.Notation A _e electrode surface area (m²) - A _e,s surface area of an electrode segment (m²) - A _{e, 1–19} total electrode surface area for the segments from 1 to 19 inclusive (m²) - A _e,a anode surface area (m²) - A _e,a,h A _e,a remaining free of bubbles (m²) - A _e,e cathode surface area (m²) - A _e,c,h A _e,c remaining free of bubbles (m²) - a ₁ parameter in Equation 7 (A^–1) - B current distribution factor - B _r B in reverse position of the cell - B _s B in standard position of cell - b _a Tafel slope for the anodic reaction (V) - b _c Tafel slope for the cathodic reaction (V) - d distance (m) - d _ac distance between the anode and the cathode (m) - d _wm distance between the working electrode and an imaginary membrane (m) (d _wm=0.5d _wt=0.5d _ac) - d _wt distance between the working and the counter electrode (m) - F Faraday constant (C mol^–1) - h height from the leading edge of the working electrode corresponding to height in the cell (m) - h _e distance from the bottom to the top of the working electrode (m) - I current (A) - I _s current for a segment (A) - I ₂₀ current for segment pair 20 (A) - I _1–19 total current for the segment pairs from 1 to 19 inclusive (A) - i current density (A m^–2) - i _av average current density of working electrode (A m^–2) - i _b current density at the bottom edge of the working electrode (A m^–2) - i ₀ exchange current density (A m^–2) - i _0,a i ₀ for anode reaction (A m^–2) - i _l current density at the top edge of the working electrode (A m^–2) - n ₁ parameter in Equation 15 - n _s number of a pair of segments of the segmented electrodes from their leading edges - Q _g volumetric rate of gas saturated with water vapour (m³ s^–1) - Q ₁ volumetric rate of liquid (m³ s^–1) - R resistance of solution () - R ₂₀ resistance of solution between the top segments of the working and the counter electrode () - R _p resistance of bubble-free solution () - R _p,20 R _p for segment pair 20 () - r _s reduced specific surface resistivity - r _s,0 r _s ath=0 - r _s,20 r _s for segment pair 20 - r _s, r _s for uniform distribution of bubbles between both the segments of a pair - r _s,,20 r _s, for segment pair 20 - T temperature (K) - U cell voltage (V) - U _r reversible cell voltage (V) - v ₁ linear velocity of liquid (m s^–1) - v _1,0 v ₁ through interelectrode gap at the leading edges of both electrodes (m s^–1) - x distance from the electrode surface (m) - gas volumetric flow ratio - ₂₀ at segment pair 20 - specific surface resistivity ( m²) - _t at top of electrode ( m²) - _p for bubble-free solution ( m²) - _b at bottom of electrode ( m²) - thickness of Nernst bubble layer (m) - ₀ ath=0 (m) - _{0,i 0} ati - voidage - _x,0 atx andh=0 - _0,0 voidage at the leading edge of electrode wherex=0 andh=0 - _0,0 ati _b - _0,0 ati=i _t - _,h voidage in bulk of solution at heighth - _,20 voidage in bubble of solution at the leading edge of segment pair 20 - _lim maximum value of _0,0 - overpotential (V) - _a anodic overpotential (V) - _c cathodic overpotential (V) - _h hyper overpotential (V) - _h,a anodic hyper overpotential (V) - _h,c cathodic hyper overpotential (V) - fraction of electrode surface area covered by of bubbles - _a for anode - _c for cathode - resistivity of solution ( m) - _p resistivity of bubble-free solution ( m)     

我国流行的4株狂犬病街毒株G基因序列及分子流行病学研究

目的探讨我国流行的狂犬病毒(RV)基因差异,评价现有疫苗的适用性。方法通过RT-PCR并对其产物测序后获得4株RV街毒株的G基因序列以及G与M和L基因的区间序列。利用计算机分析软件比较4株RV与已经发表的毒株的核苷酸和推导的氨基酸序列。结果糖蛋白(GP)完整的编码基因序列长度为1575 bp。GP氨基酸序列同源性明显高于相应的核苷酸序列(除Mokola外),4株街毒与CTN的同源性高于aG株。GP不同区段比较显示,膜外区同源性高于膜内区。G-M区间核苷酸序列长度为5 bp;除广西4外,其余毒株100％同源。GL区间核苷酸序列长度为2,4 bp,越1与肥东同源性为100％。结论4株RV均属于基因I型。广西的毒株之间存在不同的来源。街毒与疫苗株之间基因存在差异。4株RV与SAD-B19进化途径相近,与PV株相差较远。越1与肥东株亲缘关系极近,可能是由同一毒株演化而来。     

武汉地区呼吸道合胞病毒分离株的G蛋白基因遗传特征

目的分析武汉地区人呼吸道合胞病毒(RSV)分离株的G蛋白基因的遗传特征。方法使用不同的特异性引物,对武汉地区2006年分离的9株RSV进行G基因3′末端第2个高变区的序列测定,并进行基因分型和基因亲缘关系分析。结果分离的9株RSV中,33.3%(3/9)为A亚型,属GA2基因型;66.7%(6/9)为B亚型,其中1株属于BA基因型,5株属于GB8基因型。9株RSVG蛋白与原型株核苷酸同源性为84.5%～99.0%,且与原型株相比,在205～230位氨基酸中有5～8个位点氨基酸变异,还存在糖基化位点的改变。结论2006年初在武汉地区存在着由不同RSV株引起的传播链,A、B亚型共循环,B亚型是优势流行亚型;9株RSVG蛋白与原型比较,存在明显的差异。     

33株柯萨奇病毒A组16型分离株的全基因序列分析

目的对2008～2010年北京和青岛地区流行的33株柯萨奇病毒A组16型(Coxsackie virus A16,CA16)分离株的全基因序列进行分析。方法收集2008～2010年北京和青岛地区CA16感染患者咽拭子标本,采用Vero细胞对病毒进行分离,并经噬斑纯化。提取病毒RNA,采用RT-PCR法分段扩增CA16全长基因,经序列测定和拼接后,利用DNAStar和MEGA5.10软件分析全基因序列。结果经病毒分离和噬斑纯化,共获得33株CA16分离株;33个分离株之间的核苷酸序列同源性大于90.9%,与CA16国际标准株G10各区段的核苷酸序列同源性为72.7%～89.0%,氨基酸序列同源性为79.3%～100.0%;与近年中国分离的CA16 SZ/HK08-7株同源性较高,全基因组同源性大于91.5%,各区段核苷酸序列同源性均大于83.7%;在基于VP1序列的种系进化树中,BJWG16、BJWG17、BJWG20等23个分离株属于C1亚型,其余10个分离株属于C3亚型。结论 2008～2010年北京和青岛地区流行的33株CA16分离株均为C基因型。本研究对我国CA16分子流行病学、毒力位点的研究以及疫苗株的选择具有重要意义。     

RD自生酸的酸压工艺性能实验研究

设计了一种室内实验方法,研究这种RD自生酸缓速酸的有效H＋浓度。实验测得常温下RD自生酸缓慢释放出的有效H＋浓度最高可达4.166 7 mol/L。140℃,8 MPa条件下与实验岩样的反应级数为m=1.090 1,反应速率常数k=1.974 2×10-5,反应动力学方程J=1.974 2×10-5·C1.090 1;8 MPa、500 r/min条件下活化能E a=196 06 J/mol,频率因子k0=0.005 8,变温度下的反应动力学方程J=0.005 8 exp（-19 606/RT）·C1.090 1;140℃,转速达到1 200 r/min时,H＋有效传质系数De为1.94E-07 cm2/s。70℃时,实验用的岩板在RD自生酸作用下的导流能力大于胶凝酸。     

The structural plasticity of the C terminus of p21Cip1 is a determinant for target protein recognition

The cyclin-dependent kinase inhibitory protein p21(Cip1) might play multiple roles in cell-cycle regulation through interaction of its C-terminal domain with a defined set of cellular proteins such as proliferating cell nuclear antigen (PCNA), calmodulin (CaM), and the oncoprotein SET. p21(Cip1) could be described as an intrinsically unstructured protein in solution although the C-terminal domain adopts a well-defined extended conformation when bound to PCNA. However, the molecular mechanism of the interaction with CaM and the oncoprotein SET is not well understood, partly because of the lack of structural information. In this work, a peptide derived from the C-terminal domain of p21(Cip1) that covers the binding domain of the three above-mentioned proteins was used to demonstrate that the C-terminal domain of p21 recognizes multiple ligands through its ability to adopt multiple conformations. The conformation is dictated by tertiary contacts rather than by the primary sequence of the protein. Our results suggest that the C-terminal domain of p21(Cip1) adopts an extended structure when bound to PCNA and probably when bound to the oncoprotein SET, but an alpha helix when bound to CaM.     

中蜂囊状幼虫病毒LN-QY株VP1蛋白的空间结构与B细胞抗原表位预测

目的预测中蜂囊状幼虫病毒(Chinese sacbrood virus,CSBV)LN-QY株VP1蛋白的空间结构及其B细胞抗原表位。方法以CSBV LN-QY株RNA为模板,RT-PCR扩增结构蛋白VP1基因,与pMD18-T载体连接后,转化感受态大肠杆菌DH5α,对经EcoRⅠ和HindⅢ双酶切鉴定为阳性的重组质粒进行测序,通过序列比对,获得LN-QY株VP1的核苷酸序列和推导的氨基酸序列,建立VP1结构蛋白的3D模型,在此基础上,应用DNAStar软件中的Protean模块综合分析结构蛋白的柔性区域,亲水性,表面可能性以及抗原指数等参数。结果 VP1结构蛋白的空间构象比较规则,其可能的B细胞抗原表位区域位于47-53,139-145,273-284氨基酸区段。结论本研究为CSBV LN-QY株VP1蛋白表位疫苗的设计以及血清诊断试剂盒的研制奠定了理论基础。